The results revealed a highly significant association between SLC6A6 and FMO1, the final rate-limiting enzyme in Taurine synthesis ( Figure 3 I,J), indicating that the impact of SLC6A6 on tumors is largely dependent on Taurine. 3.4.
← all excerpts
The Taurine-Slc6a6 Axis Promotes Breast Cancer Progression by Alleviating Oxidative Stress and Accelerating Cell Cycle Progression.
1
—
—